0001209191-22-021200.txt : 20220325 0001209191-22-021200.hdr.sgml : 20220325 20220325205309 ACCESSION NUMBER: 0001209191-22-021200 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220324 FILED AS OF DATE: 20220325 DATE AS OF CHANGE: 20220325 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SHERMAN STEVEN CENTRAL INDEX KEY: 0001201619 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37854 FILM NUMBER: 22772975 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EKSO BIONICS HOLDINGS, INC. CENTRAL INDEX KEY: 0001549084 STANDARD INDUSTRIAL CLASSIFICATION: GENERAL INDUSTRIAL MACHINERY & EQUIPMENT, NEC [3569] IRS NUMBER: 000000000 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1414 HARBOUR WAY SOUTH STREET 2: SUITE 1201 CITY: RICHMOND STATE: CA ZIP: 94804 BUSINESS PHONE: 510-984-1761 MAIL ADDRESS: STREET 1: 1414 HARBOUR WAY SOUTH STREET 2: SUITE 1201 CITY: RICHMOND STATE: CA ZIP: 94804 FORMER COMPANY: FORMER CONFORMED NAME: PN Med Group Inc DATE OF NAME CHANGE: 20120503 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-03-24 0 0001549084 EKSO BIONICS HOLDINGS, INC. EKSO 0001201619 SHERMAN STEVEN C/O EKSO BIONICS HOLDINGS, INC. 1414 HARBOUR WAY SOUTH, SUITE 1201 RICHMOND CA 94804 1 1 0 0 CEO & Chairman Common Stock 2022-03-24 4 S 0 6389 2.94 D 619669 D Represents shares sold by the Reporting Person on March 24, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of the second installment of a restricted stock award originally reported by the Reporting Person in Form 4 filed with the Commission on March 10, 2022. The sale price represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $2.91 to $2.9767, inclusive. The Company can provide the full information regarding the number of shares sold at each separate price upon further request. /s/ Jerome Wong, as Attorney-in-Fact 2022-03-25